Zhengye Biotechnology Ordinary Shares(Zybt) Financials: Financial Leverage Compared To Industry Average, Plus Other Key Ratios
Solvency Trend (Last 5 Years)
Solvency - financial leverage
This chart shows the historical trend of financial leverage for ZYBT compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Financial Leverage
Definition: Financial leverage tells you how much borrowed money the company uses to boost its size and profits. Using leverage can help a business grow faster, but it also increases pressure if sales slow down. Moderate leverage is common and often healthy. Excessive leverage can be dangerous, especially during tough economic times.
Interpretation:
• In '2021', ZYBT's financial leverage was 1.66, indicating how much debt is used to finance assets. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 1.45.
• In '2022', ZYBT's financial leverage was 1.71, indicating how much debt is used to finance assets. The increase compared to '2021' may signal growing financial pressure. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 1.54. Industry average increased by 0.08 compared to previous year.
• In '2023', ZYBT's financial leverage was 1.79, indicating how much debt is used to finance assets. The increase compared to '2022' may signal growing financial pressure. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.32. Industry average declined by 0.22 from previous year.
Overall, ZYBT's financial leverage has steadily improved over the past 3 years.
Formula: Financial Leverage = Average Total Assets / Average Shareholders' Equity
Good Range: 1 to 3 common; above 3 may indicate high leverage risk.